The Hospital Readmission Reduction Program is a recent policy designed to save the government money by imposing large financial penalties on hospitals whose readmission rates for certain medical conditions are found to be higher than the national average. Could pushing policy levers on such a grand scale conceivably have negative unintended consequences?…
Our guest is Dr. Ankur Gupta, author of a 2017 JAMA article that examined mortality rates in heart failure in the aftermath of the HRRP development and implementation. Dr. Gupta is an interventional cardiology fellow at University of Texas Southwestern Medical Center in Dallas. He holds and MD from the All India Institute of Medical Sciences (New Delhi) and an interdisciplinary PhD in statistics and computational fluid dynamics from the University of Alabama.
Ankur Gupta, MD. Twitter
Gupta A, Allen LA, Bhatt Deepak, et al. Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure. (Open Access in JAMA, 2017)
Gupta A, Fonarow G. The Hospital Readmission Reduction Program: Evidence for Harm. (in JACC: Heart Failure 2018)
Khera R, Dhamarajan K, Wang Yonfei, et al. Association of the Hospital Readmissions Reduction Program With Mortality During and After Hospitalization for Acute Myocardial Infarction, Heart Failure, and Pneumonia. (Article from Dr. Krumholz’s group in JAMA 2018, Open Access)
Khera R, Dhamarajan K, Krumholz H. Rising mortality in patients with Heart Failure in the United States. (Counterpoint to Dr. Gupta’s analysis in JACC: Heart Failure 2018)
WATCH ON YOUTUBE:
Watch the episode on our YouTube channel.